Skip to content

Replimune Group REPL Free cash flow yield

Free cash flow yield at other companies

Amgen logo
AmgenAMGN
4.5%-2.0pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5%+0.6pp
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-13.4%-6.1pp
Immunome logo
ImmunomeIMNM
-8.3%-3.4pp
CG Oncology logo
CG OncologyCGON
-2.8%-0.7pp
Erasca, Inc. logo
Erasca, Inc.ERAS
-1.8%-0.9pp

Other financials

Income statement

See full
Operating income-$71.9M-8.9%
Net income-$70.9M-6.9%
EPS (diluted)-$0.77+2.5%

Balance sheet

See full
Cash & equivalents$124.7M-28.3%
Total debt$79.2M+0.5%
Total equity$210.5M-56.4%
Total assets$333.6M-44.7%

Cash flow

See full
Operating cash flow-$66.0M-30.1%
CapEx$135.0K-92.5%
Free cash flow-$66.1M-25.9%

Valuation

See full
Market cap$930.59M+30.2%
Enterprise value$885.15M+30.0%

Returns & leverage

See full
Return on equity-90.9%+362pp
Debt / equity0.4×+0.2×
Current ratio5.6×-5.8×

Where this comes from

Calculated from Replimune Group’s reported figures.

Based on trailing twelve months.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Replimune Group's free cash flow yield?
Replimune Group (REPL) reported free cash flow yield of -37.2% in Q4 2025.
How has Replimune Group's free cash flow yield changed year-over-year?
Replimune Group's free cash flow yield decreased by 80.3% year-over-year, from -20.6% to -37.2%.
What is the long-term trend for Replimune Group's free cash flow yield?
Over 4 years (2021 to 2025), Replimune Group's free cash flow yield has grown at a 56.1% compound annual growth rate (CAGR), from -4.5% to -26.5%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.